Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Stroke peptide trials
6 selected ClinicalTrials.gov records carrying the official condition label Stroke. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
6 selected records.
2 profiles.
2009–2019 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 56 selected PubMed records and 15 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Stroke unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00840671
PeptideScanner retained ClinicalTrials.gov record NCT00840671 at 2026-11-16T17:33:14.861Z. Its registry update date was 2010-12-28, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 28, 2010
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01388738
PeptideScanner retained ClinicalTrials.gov record NCT01388738 at 2026-11-16T17:33:14.861Z. Its registry update date was 2011-12-23, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 23, 2011
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02768571
PeptideScanner retained ClinicalTrials.gov record NCT02768571 at 2026-11-16T17:33:14.861Z. Its registry update date was 2019-09-20, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 20, 2019
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Cerebrolysin · 2019-09-20
ClinicalTrials.gov record NCT02768571
Completed at the retained observation.
Open attributed record →Eptifibatide · 2016-01-21
ClinicalTrials.gov record NCT01977456
Completed at the retained observation.
Open attributed record →Eptifibatide · 2014-04-17
ClinicalTrials.gov record NCT00894803
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2011-12-23
ClinicalTrials.gov record NCT01388738
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2010-12-28
ClinicalTrials.gov record NCT00840671
Completed at the retained observation.
Open attributed record →Eptifibatide · 2009-05-08
ClinicalTrials.gov record NCT00250991
Completed at the retained observation.
Open attributed record →